(2015). Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: The GLOW7 study [Corrigendum]. Int J Chron Obstruct Pulmon Dis.
Citação norma Chicago"Efficacy and Safety of Once-daily Glycopyrronium in Predominantly Chinese Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease: The GLOW7 Study [Corrigendum]." Int J Chron Obstruct Pulmon Dis 2015.
MLA Citation"Efficacy and Safety of Once-daily Glycopyrronium in Predominantly Chinese Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease: The GLOW7 Study [Corrigendum]." Int J Chron Obstruct Pulmon Dis 2015.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.